Serum Institute of India (SII)

CERVAVAC: Cervical Cancer Vaccine

The cervix is the lowermost part of the uterus. Tumour in the cervix is generally referred to as cervical cancer. A vaccine to cure cervical cancer was recently launched by the Serum Institute of India. The name of the vaccine ..

Month: 

Category: 

SII: Anti-cervical cancer vaccine

On July 12, 2022, the CEO of Serum Institute of India (SII) Adar Poonawalla announced company’s plans to roll out its indigenously-developed vaccine for the prevention of cervical cancer among women. Highlights The Drugs Controller General of India (DCGI) has also accorded ..

Month: 

Category: 

Conditional market approval for Covaxin, Covishield

The Drug regulator in India has granted conditional market approval for the COVISHIELD and COVAXIN vaccines. This means that the private hospitals shall administer the vaccines. However, the vaccines will not be available in retail medical stores. What is conditional ..

Month: 

Category: 

Padma Awards 2022

The Padma Awards 2022 is to be conferred to vaccine makers to semiconductor market rulers. This time, the Padma awards are being presented to a diversified list of recipients. Around 128 people are to receive the award in 2022. The ..

Month: 

Category: 

WHO gives emergency approval for Covovax vaccine

On December 17, 2021, World Health Organisation (WHO) gave approval for emergency use of Covovax vaccine for Children. Key Points WHO listed the Covovax as ninth COVID-19 vaccine for emergency use. This move is aimed at increasing the access to ..

Month: 

Italy recognizes India’s Covishield Vaccine

Italy has recognised Covishield vaccine against the Coronavirus on September 24, 2021. Highlights Covieshield vaccine against coronavirus was jointly developed by Oxford University & pharma giant AstraZeneca while it was manufactured by the Serum Institute of India. With this recognition ..

Month: